Why did Procter and Gamble Hygiene (PGHH) stock move recently?

On 7/29/2026, Procter and Gamble Hygiene moved -4.2% — PGHH fell in a stock-specific sell-off and hit a 52-week low while broader markets rallied; no company-specific news or filing explains the move. This is MarketChacha's decoded reason from filings and credible news; it is education, not buy/sell advice.

Is Procter and Gamble Hygiene (PGHH) overvalued or fairly valued?

MarketChacha shows Procter and Gamble Hygiene's valuation in context — a forward P/E of about 25.9, a price-to-book of about 33.0 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Procter and Gamble Hygiene's revenue?

Procter and Gamble Hygiene reported revenue of ₹4,290 Cr for FY2026, with net profit of ₹857 Cr, per official filings.

What is the share price of Procter and Gamble Hygiene (PGHH)?

Procter and Gamble Hygiene last traded at ₹7,667.50 (-1.2% on the day), as of 9/4/2026 — a delayed quote shown for education, not investment advice.

Procter and Gamble Hygiene

PGHH · NSE · FMCG · India

Snapshot

TickerPGHH

ExchangeNSE

SectorFMCG

IndustryHousehold & Personal Products

CountryIndia

HeadquartersMumbai, India

Websitein.pg.com

Filings tracked0

About Procter and Gamble Hygiene

Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Health care Products and Hygiene Products segments. The company offers health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also provides baby care products comprising nappies, pants, and baby wipes; grooming products; laundry products; hair care products; home, personal and skin care, and oral products. The company sells its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brands through mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of The Procter & Gamble Company.

Who owns it

Promoters70.9%
Institutions14.3%
Public & other14.8%

42 institutional holders

Ownership breakdown from public market data. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Net margin trend17.3% → 20.0%

Margin has expanded by about 2.7 points — the business is getting more profitable.

Growth qualityrev 2% · PAT 6%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (Yahoo Finance). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev ₹1,350 Cr · EPS 86.90

Est. earnings growth -6.4%

Next fiscal year

Rev ₹4,883 Cr · EPS 296.40

Est. earnings growth +11.1%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: Yahoo Finance

Annual

Quarterly · last 5

Revenue (FY2026)

₹4,290 Cr

Net margin

20.0%

Revenue CAGR (3y)

+3.1%

Profit CAGR (3y)

+8.1%

Net profit (FY2026)

₹857 Cr

Ask MarketChacha about PGHH

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

Jul 29, 2026
PGHH fell in a stock-specific sell-off and hit a 52-week low while broader markets rallied; no company-specific news or filing explains the move.
source 1 ↗· confidence: medium

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

Period	Revenue	Net profit	Net margin
FY2026	₹4,290 Cr	₹857 Cr	20.0%
FY2025	₹4,311 Cr	₹829 Cr	19.2%
FY2024	₹4,206 Cr	₹675 Cr	16.1%
FY2023	₹3,918 Cr	₹678 Cr	17.3%

Quarterly

Period	Revenue	Net profit	Net margin
Q1 FY27	₹891 Cr	₹126 Cr	14.2%
Q4 FY26	₹941 Cr	₹153 Cr	16.3%
Q3 FY26	₹1,262 Cr	₹301 Cr	23.9%
Q2 FY26	₹1,150 Cr	₹210 Cr	18.2%
Q1 FY26	₹937 Cr	₹192 Cr	20.5%

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.